You searched for Humanized antibody - Page 17 of 44

News and Trends 17 Sep 2019

European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm

…aim to stop relapses in the most common form of the condition, known as relapsing-remitting multiple sclerosis. The Danish antibody developer Genmab presented results from its drug ofatumumab, which is…

September 17, 2019 - 4 minutesmins - By Jonathan Smith

Best in Biotech 22 Jan 2025

Curing ALS? Sixteen companies developing new treatments in 2025

…novel antibody-based therapeutics for ALS. This partnership leverages Alchemab’s discovery platform to identify potential therapeutic antibodies from patients exhibiting slow ALS progression. While specific development stages of these candidates have…

January 22, 2025 - 18 minutesmins - By Jules Adam

News and Trends 21 Feb 2023

Biocytogen launches nanobody therapeutics project for 100 targets

…therapy, bispecific antibody and engager, multi-specific antibody, antibody drug-conjugate (ADC), and radionuclide antibody-conjugate (RAC). After several years of work, Biocytogen successfully engineered the RenNano mouse from its fully human antibody…

February 21, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 22 Apr 2025

Seven biotechs to watch in the hepatitis B space

…its pipeline when it went public for $110.5 million in May 2021. Bluejay Therapeutics Therapeutic candidate: BJT-778 Technology: monoclonal antibody Recent funding: $182 million series C Another California-based biotech, Bluejay Therapeutics,…

April 22, 2025 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 14 Feb 2023

Scancell looking to partner after positive COVID vaccine data

…cell response. RBD neutralizing antibody titres against the Beta variant doubled in 44% of subjects and NCAP antibody titres doubled in 42% of participants. Scancell said of particular interest was…

February 14, 2023 - 5 minutesmins - By Jim Cornall

CureVac: From a failed mRNA-based COVID-19 vaccine to a €400 million deal with GSK

In Depth 1 Aug 2024

CureVac: From a failed drug to a €1.45 billion deal

…trials began in mid-2020, with phase 1 and 2a trials showing that CVnCoV was generally well tolerated and induced strong antibody responses comparable to those seen in recovered COVID-19 patients….

August 1, 2024 - 8 minutesmins - By Jules Adam

organoids in a dish, drug development, patient relevant model

The organoid era: bringing patient-relevant preclinical models to the lab

…in Nature Cancer demonstrating the role of patient-derived organoids in the preclinical development and validation of a new bispecific antibody. This collaborative work by the European consortium (SuppresSTEM), coordinated by…

July 12, 2022 - 7 minutesmins - By Sudha Sundaram

News and Trends 3 Aug 2022

AbCellera and Atlas Venture to collaborate on new company for therapeutic antibody discovery

…transforming innovative scientific research into exciting new biotechs,” said Carl Hansen, CEO and president of AbCellera. “By eliminating their need to build internal antibody discovery capabilities at inception, we provide…

August 3, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Aug 2025

Top biotech deals in July 2025

…IGM Biosciences and iTeos Therapeutics, both of which experienced significant lows this year. The $82 million deal with IGM came after the antibody developer was ditched by Sanofi in May,…

August 8, 2025 - 8 minutesmins - By Roohi Mariam Peter

More News! 20 Jun 2017

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

…ARGX-112, though an amount has not been disclosed. The antibody, indicated for inflammatory skin diseases, was discovered with the biotech’s SIMPLE discovery platform. The Belgian biotech will carry out preclinical…

June 20, 2017 - 1 minutemin - By Evelyn Warner

Interview 9 Oct 2017

The Woman Developing the Next Generation of Cancer Immunotherapy

…so far and putting its unique antibody technology one step closer to patients. As she continues at Ganymed by supporting the new owners in their takeover of late-stage antibody development,…

October 9, 2017 - 8 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 8 Mar 2017

Which European Blockbusters Topped the Charts in 2016?

…is a monoclonal antibody used to treat breast cancers, which are HER2–positive. The antibody binds to the HER2 receptor overexpressed on some breast cancers, thereby inhibiting the proliferation of these…

March 8, 2017 - 4 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm

Curing ALS? Sixteen companies developing new treatments in 2025

Biocytogen launches nanobody therapeutics project for 100 targets

Seven biotechs to watch in the hepatitis B space

Scancell looking to partner after positive COVID vaccine data

CureVac: From a failed drug to a €1.45 billion deal

The organoid era: bringing patient-relevant preclinical models to the lab

AbCellera and Atlas Venture to collaborate on new company for therapeutic antibody discovery

Top biotech deals in July 2025

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

The Woman Developing the Next Generation of Cancer Immunotherapy

Which European Blockbusters Topped the Charts in 2016?

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!